fr

EN DE

fr

EN DE

Publications

2108 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2023

Bioconjugate chemistry

Brion A

Photoactivatable Liposomes for Blue to Deep Red Light-Activated Surface Drug Release: Application to Controlled Delivery of the Antitumoral Drug Melphalan.

2023

Diagnostics (Basel, Switzerland)

Durot C

Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab Maintenance.

2023

Cancers

Eber J

Evaluation of Cardiac Substructures Exposure of DIBH-3DCRT, FB-HT, and FB-3DCRT in Hypofractionated Radiotherapy for Left-Sided Breast Cancer after Breast-Conserving Surgery: An In Silico Planning Study.

2023

Cytokine

Paul C

Additional value of interleukin-6 level to predict histopathological features of hepatocellular carcinoma before liver transplantation.

2023

Hernia : the journal of hernias and abdominal wall surgery

Louis V

How I do it: using a hammock mesh in the reconstruction of inguinal ligament during a wide en-bloc resection of a groin mesenchymal tumor.

2023

Biomedicines

Nounsi A

Patient-Derived Tumoroid for the Prediction of Radiotherapy and Chemotherapy Responses in Non-Small-Cell Lung Cancer.

2023

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Thomas A

Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective.

2023

Cancer treatment and research communications

Bender L

Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer.

2023

Computer methods and programs in biomedicine

Simoulin A

From free-text electronic health records to structured cohorts: Onconum, an innovative methodology for real-world data mining in breast cancer.

2023

Frontiers in oncology

Curtit E

Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis.